Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. - Parker,R.J.; Eastman,A.; Bostick-Bruton,F.; Reed,E. (J Clin Invest, 1991)